The Right Time and " Pl ACE": Optimal Management of Perioperative Angiotensin-Converting Enzyme Inhibitors

被引：2
|
作者：
Chopra, Vineet [1 ,2 ]
Wijeysundera, Duminda N. [3 ,4 ,5 ]
机构：
[1] Ann Arbor VA Healthcare Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA
[2] Univ Michigan Hlth Syst, Dept Med, Ann Arbor, MI USA
[3] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada
[4] Toronto Gen Hosp, Dept Anesthesia, Toronto, ON, Canada
[5] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF HOSPITAL MEDICINE | 2014年 / 9卷 / 05期
基金：
加拿大健康研究院;
关键词：
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; CLINICAL CONSEQUENCES; SYSTEM ANTAGONISTS; NONCARDIAC SURGERY; MORTALITY;
D O I：
10.1002/jhm.2203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：334 / 336
页数：3
相关论文
共 50 条
  • [31] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
    Xiao, Lin
    Ouyang, Haichun
    Su, Qiwen
    Huang, Yuli
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 56 - 57
  • [32] Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients
    Kido, Ryo
    Akizawa, Tadao
    Fukagawa, Masafumi
    Onishi, Yoshihiro
    Yamaguchi, Takuhiro
    Fukuhara, Shunichi
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (06) : 439 - 447
  • [33] Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the mortality in sepsis: A meta-analysis
    Yang, Deng-Can
    Xu, Jian
    Jian, Li
    Yu, Yi
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (36)
  • [34] Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: Challenges in Comparative Effectiveness Using Medicare Data
    Setoguchi, S.
    Shrank, W. H.
    Liu, J.
    Lee, J. C.
    Saya, U.
    Winkelmayer, W. C.
    Dreyer, N. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (05) : 674 - 682
  • [35] Relating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers with incidence or mortality of COVID-19
    Wong, Martin C. S.
    Wong, Sunny
    Huang, Junjie
    Yan, Bryan
    ESC HEART FAILURE, 2020, 7 (05): : 3119 - 3123
  • [36] The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis
    Song, Taejong
    Choi, Chel Hun
    Kim, Mi Kyoung
    Kim, Mi-La
    Yun, Bo Seong
    Seong, Seok Ju
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2017, 26 (01) : 78 - 85
  • [37] Interaction Between Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-Converting Enzyme Inhibition on Survival in Hemodialyzed Patients
    Kiss, Istvan
    Ambrus, Csaba
    Kulcsar, Imre
    Szegedi, Janos
    Kerkovits, Lorant
    Tisler, Andras
    Kiss, Zoltan
    MEDICINE, 2014, 93 (28) : e315
  • [38] Comparison of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Management Strategies Before Cardiac Surgery: A Pilot Randomized Controlled Registry Trial
    van Diepen, Sean
    Norris, Colleen M.
    Zheng, Yinggan
    Nagendran, Jayan
    Graham, Michelle M.
    Ortega, Damaris Gaete
    Townsend, Derek R.
    Ezekowitz, Justin A.
    Bagshaw, Sean M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (20):
  • [39] Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury
    Suberviola, B.
    Rodrigo, E.
    Gonzalez-Castro, A.
    Serrano, M.
    Heras, M.
    Castellanos-Ortega, A.
    MEDICINA INTENSIVA, 2017, 41 (01) : 21 - 27
  • [40] Up-titrating angiotensin-converting enzyme inhibitors in heart failure: evidence and challenges
    Savarese, Gianluigi
    Lund, Lars H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (02) : 370 - 372
12345